BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Africa\, race and the most expensive vaccine yet: stakes of hepati
 tis B immunisation research in Senegal and the Gambia - Noémi Tousignant 
 (University College London)
DTSTART:20201112T153000Z
DTEND:20201112T170000Z
UID:TALK130714@talks.cam.ac.uk
CONTACT:Helen Curry
DESCRIPTION:Among the earliest and most ambitious experiments of hepatitis
  B vaccine happened in West Africa from the mid 1970s to the mid 1980s. Ye
 t both plasma and recombinant vaccines for this virus\, which hit the mark
 et as the most expensive vaccines yet\, were not widely provided in Africa
  until the 2000s. In this paper\, I examine relations and disjunctions bet
 ween the politics of experimentation and those of vaccine distribution acr
 oss spaces (and times) of economic\, epidemiological and racialised differ
 ence. My focus is on the planning of a research programme partially implem
 ented in Senegal from the late 1970s\, and another launched in 1986 as the
  Gambia Hepatitis Intervention Study. I show how the logics underpinning t
 his research – to use vaccination as an experimental device for generati
 ng aetiological evidence of viral cancer causation – made it acceptable 
 to test a technology that was expected to remain 'too expensive for Africa
 ' in the foreseeable future\, and discuss how not just patterns of accessi
 bility but their modes of rendering acceptable were racialised.
LOCATION:Zoom
END:VEVENT
END:VCALENDAR